SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. Kauh, L. Mixson, M.-P. Malice, S. Mesens, S. Ramael, J. Burke, T. Reynders, K. Van Dyck, C. Beals, E. Rosenberg, M. Ruddy, Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals, European Journal of Endocrinology, 2012, 166, 3, 459

    CrossRef

  2. 2
    I Leonard Bernstein, James T. Li, David I. Bernstein, Robert Hamilton, Sheldon L. Spector, Ricardo Tan, Scott Sicherer, David B.K. Golden, David A. Khan, Richard A. Nicklas, Jay M. Portnoy, Joann Blessing-Moore, Linda Cox, David M. Lang, John Oppenheimer, Christopher C. Randolph, Diane E. Schuller, Stephen A. Tilles, Dana V. Wallace, Estelle Levetin, Richard Weber, Allergy Diagnostic Testing: An Updated Practice Parameter, Annals of Allergy, Asthma & Immunology, 2008, 100, 3, S1

    CrossRef

  3. You have free access to this content3
    G. K. Scadding, S. R. Durham, R. Mirakian, N. S. Jones, S. C. Leech, S. Farooque, D. Ryan, S. M. Walker, A. T. Clark, T. A. Dixon, S. R. A. Jolles, N. Siddique, P. Cullinan, P. H. Howarth, S. M. Nasser, BSACI guidelines for the management of allergic and non-allergic rhinitis, Clinical & Experimental Allergy, 2008, 38, 1
  4. 4
    Cherie M. Pucheu-Haston, Dale Shuster, Thierry Olivry, Philippe Brianceau, Patrick Lockwood, Terrill McClanahan, Rene Waal Malefyt, Jeanine D. Mattson, Bruce Hammerberg, A canine model of cutaneous late-phase reactions: prednisolone inhibition of cellular and cytokine responses, Immunology, 2006, 117, 2
  5. 5
    Luis M Salmun, Antihistamines in late-phase clinical development for allergic disease, Expert Opinion on Investigational Drugs, 2002, 11, 2, 259

    CrossRef

  6. 6
    Jean Bousquet, Paul van Cauwenberge, Nikolai Khaltaev, Allergic Rhinitis and Its Impact on Asthma, Journal of Allergy and Clinical Immunology, 2001, 108, 5, S147

    CrossRef

  7. 7
    P. N. Nielsen, P. S. Skov, L. K. Poulsen, M. Schmelz, L. J. Petersen, Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study, Clinical & Experimental Allergy, 2001, 31, 9
  8. 8
    Garry M. Walsh, Lucio Annunziato, Nelly Frossard, Klaas Knol, Sten Levander, Jean-Marie Nicolas, Maurizo Taglialatela, Michael D. Tharp, Jean P. Tillement, Henk Timmerman, New Insights into the Second Generation Antihistamines, Drugs, 2001, 61, 2, 207

    CrossRef

  9. 9
    F Estelle R Simons, Lana Johnston, Xiaochen Gu, Keith J Simons, Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast, Annals of Allergy, Asthma & Immunology, 2001, 86, 1, 44

    CrossRef

  10. 10
    P. Van Cauwenberge, C. Bachert , G. Passalacqua , J. Bousquet , G. W. Canonica , S. R. Durham , W. J. Fokkens , P. H. Howarth , V. Lund , H.-J. Malling , N. Mygind , D. Passali , G. K. Scadding , D.-Y. Wang , Consensus statement on the treatment of allergic rhinitis, Allergy, 2000, 55, 2
  11. 11
    H.-U. Simon, Eosinophil apoptosis – pathophysiologic and therapeutic implications, Allergy, 2000, 55, 10
  12. 12
    A. Karppinen, H. Kautiainen, T. Reunala, L. Petman, T. Reunala, H. Brummer-Korvenkontio, Loratadine in the treatment of mosquito-bite-sensitive children, Allergy, 2000, 55, 7
  13. 13
    Elisabeth G. Langeveld-Wildschut, Hannes Riedl, Theo Thepen, Ilse C. Biharia, Piet L.B. Bruijnzeel, Carla A.F.M. Bruijnzeel-Koomen, Modulation of the atopy patch test reaction by topical corticosteroids and tar, Journal of Allergy and Clinical Immunology, 2000, 106, 4, 737

    CrossRef

  14. 14
    Garry M. Walsh, The anti-inflammatory effects of the second-generation antihistamines, Dermatologic Therapy, 2000, 13, 4
  15. 15
    G. M. Walsh, The clinical relevance of the anti-inflammatory properties of antihistamines, Allergy, 2000, 55,
  16. 16
    J. Bousquet, What are the perspectives in the future for H1-antihistamines ?, Revue Française d'Allergologie et d'Immunologie Clinique, 2000, 40, 1, 82

    CrossRef

  17. 17
    S. Hayashi, S. Hashimoto, Anti-inflammatory actions of new antihistamines, Clinical & Experimental Allergy, 1999, 29, 12
  18. 18
    A. Leusink-Muis, R. Ten Broeke, G. Folkerts, F. DE Clerck, F.P. Nijkamp, Betamethasone prevents virus-induced airway inflammation but not airway hyperresponsiveness in guinea pigs, Clinical & Experimental Allergy, 1999, 29,
  19. 19
    C. De Vos, H1-receptor antagonists: effects on leukocytes, myth or reality?, Clinical & Experimental Allergy, 1999, 29, S3
  20. 20
    Eli O. Meltzer, J. Andrew Grant, Impact of cetirizine on the burden of allergic rhinitis, Annals of Allergy, Asthma & Immunology, 1999, 83, 5, 455

    CrossRef

  21. 21
    Burton Zweiman, Anne R. Moskovitz, Carolyn von Allmen, Comparison of inflammatory events in skin sites with and without cutaneous late-phase reactions after prominent immediate IgE-mediated responses, Journal of Allergy and Clinical Immunology, 1998, 101, 1, 110

    CrossRef

  22. 22
    Dean A Handley, Anthony Magnetti, Alan J Higgins, Therapeutic advantages of third generation antihistamines, Expert Opinion on Investigational Drugs, 1998, 7, 7, 1045

    CrossRef

  23. 23
    Luis T. Barata, Sun Ying, J. Andrew Grant, Marc Humbert, Julia Barkans, Qui Meng, Stephen R. Durham, A. Barry Kay, Allergen-induced recruitment of FcσRI+ eosinophils in human atopic skin, European Journal of Immunology, 1997, 27, 5
  24. 24
    Paul Cauwenberge, Deyun Wang, Antihistamines and nasal blockage, Allergy, 1997, 52,
  25. 25
    J. A. GRANT, The clinical efficacy of antihistamines in the upper and lower airway, Clinical & Experimental Allergy, 1997, 27,
  26. 26
    G. M. WALSH, The effects of cetirizine on the function of inflammatory cells involved in the allergic response, Clinical & Experimental Allergy, 1997, 27,